<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="220409">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00214448</url>
  </required_header>
  <id_info>
    <org_study_id>05-801</org_study_id>
    <nct_id>NCT00214448</nct_id>
  </id_info>
  <brief_title>Reproducibility of the Array-Based Comparative Genomic Hybridization (aCGH) System Using Whole Blood Samples</brief_title>
  <official_title>Reproducibility of the GeneTraitâ„¢ CGH Microarray System DX Using Whole Blood Samples</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Molecular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Molecular</source>
  <brief_summary>
    <textblock>
      The objective of this study is to validate the performance characteristics of the GeneTrait
      CGH Microarray System DX. Reproducibility among sites, lots, and operators will be
      evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Cross-Sectional, Prospective</time_perspective>
  </study_design_info>
  <enrollment>4</enrollment>
  <condition>Genetic Disorders</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be able to donate at least 10 mL of whole blood

          -  Must be able to provide consent, or parental consent and patient assent (if
             applicable)

          -  Must be currently followed as a patient of a genetic clinic or counselor at one of
             the recruiting sites

          -  Must have at least one chromosomal change that is detectable by the GeneTrait CGH
             Microarray System DX as determined by karyotype and/or fluorescence in situ
             hybridization (FISH) analysis (within any of the 73 critical regions)

        Exclusion Criteria:

          -  Unable to donate at least 10 mL of whole blood

          -  Unable to provide consent, or parental consent and patient assent (if applicable)

          -  Not currently followed as a patient of a genetic clinic or counselor at one of the
             recruiting sites

          -  Does not have at least one chromosomal change that is detectable by the GeneTrait CGH
             Microarray System DX as determined by karyotype and/or FISH analysis (within any of
             the 73 critical regions)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lynda Hague</last_name>
    <phone>224-361-7101</phone>
    <email>lynda.hague@abbott.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrew Hiar</last_name>
    <phone>224-361-7056</phone>
    <email>andrew.hiar@abbott.com</email>
  </overall_contact_backup>
  <verification_date>September 2005</verification_date>
  <lastchanged_date>July 13, 2006</lastchanged_date>
  <firstreceived_date>September 20, 2005</firstreceived_date>
  <keyword>Multiple genetic conditions will be studied</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
